News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Biocon Biologics Acquires Viatris' Global Biosimilars Business
Wednesday, November 30, 2022Biocon Biologics Ltd BBL has successfully completed its multibillion dollar acquisition of the global biosimilars business of its partner Viatris Inc This acquisition builds on Biocons longstanding strategic partnership with Viatris and is a historic...
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline
Tuesday, November 29, 2022FullLife Technologies a global radiotherapeutics company has announced its agreement to acquire FocusX Therapeutics a New Jerseybased company specializing in targeted radiopharmaceuticals for cancer treatment FocusX utilizes proprietary peptide engin...
Ferinject® approved in China for the treatment of iron deficiency in adult patients
Tuesday, November 29, 2022CSL Vifor and Fresenius Kabi today announced that Chinas National Medical Products Administration NMPA has approved Ferinject a preparation for intravenous iron therapy for the treatment of iron deficiency in adult patients for whom oral iron prepara...
US Partial Clinical Hold on Diamyd® Phase III Trial Lifted by the FDA
Monday, November 28, 2022Diamyd Medical has announced that the US Food and Drug Administration FDA has lifted the partial clinical hold on the confirmatory Phase III trial DIAGNODE The trial aims to evaluate the safety and efficacy of Diamyd a precision medicine and antigens...
Envirotainer significantly expands global CryoSure® network with new Singapore station
Friday, November 25, 2022Envirotainer the global market leader in secure cold chain solutions for shipment of pharmaceuticals has opened a new CryoSure station in Singapore This significantly expands global availability of the ultracold solution for the transportation of med...
Grünenthal and Kyowa Kirin International Announce Joint Venture Collaboration for Established Medicines Portfolio
Friday, November 25, 2022Kyowa Kirin Co Ltd a Japanbased global specialty pharmaceutical company and Grnenthal GmbH a global sciencebased privatelyowned pharmaceutical company are today announcing they have signed a Joint Venture Collaboration for Kyowa Kirin Internationals...
Iktos Partners with Medicines for Malaria Venture in Anti-Malarial Drug Discovery
Thursday, November 24, 2022Iktos a leader in Artificial Intelligence for new drug design today announced a collaboration with Medicines for Malaria Venture MMV a leading product development partnership PDP in the field of antimalarial drug research and development Under this c...
AcuCort signs its first commercial agreement for the company's drug Zeqmelit™
Thursday, November 24, 2022AcuCort AB announces that the company has signed an exclusive commercial agreement with the global biopharmaceutical company Kamada Ltd The agreement gives Kamada the exclusive right to the marketing and sales as well as the distribution of AcuCorts...
Glenmark Pharmaceuticals reaches settlement agreement with Pfizer for Axitinib Tablets, 1 mg and 5 mg
Wednesday, November 23, 2022Glenmark Pharmaceuticals Inc USA Glenmark and Glenmark Pharmaceuticals Limited have reached a settlement agreement with Pfizer Inc PF Prism CV and PF Prism IMB BV Pfizer for Axitinib Tablets mg and mg the generic version of their Inlyta Tablets mg...
Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID
Wednesday, November 23, 2022Tevogen Bio a latestage clinical biotechnology company specializing in the development of cellular immunotherapies in oncology neurology and virology announced today its intention
